Meldex International is a specialty pharma company that has reached an exciting phase in its development. Meldex International has turned itself into the company it is today by using a buy and build approach. The acquisitions Meldex International has made in the US, France and Italy is the beginning of a pan-European and US distribution network. It has also set up a sales subsidiary in the UK through which the first products will be launched this year. Meldex International is looking to fill the gaps in its current European coverage and so are interested in the acquisition of companies in the correct territories.

Meldex International's business strategy is centred around the use of its portfolio of enabling technologies used to develop medicines and nutritional products that are more convenient to use. In particular, the company is focused on patient groups such as children and the elderly, who may have difficulty with tablets, and on patient supportive care, which encompasses areas such as pain management and anti-emesis. It is for this reason that Meldex International is interested in acquiring brands from which it can launch line extensions that employ its technologies.

These novel products will be launched using its European and US distribution operations. Meldex International is also interested in out-licensing these novel products to companies in territories where it does not have any sales and marketing capability.

Meldex International continues to develop and patent novel enabling technologies. Meldex International currently has six enabling technologies, however is continuously developing new ones, either through collaborations with partners or via in-house development in response to customer requests.

1. Form partnerships with companies wishing to enhance the value of their products through combination with Meldex International enabling technologies 

2. Out licensing - form partnerships with companies wishing to market and sell Meldex International products in specified geographic territories 

3. Product acquisition / partnerships - Meldex International is actively seeking to acquire the rights to market and sell late phase / marketed products in Europe and the USA.     

4. Company acquisitions - Meldex International is actively seeking to acquire European and USA based companies.